| Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19 JA Hosp, A Dressing, G Blazhenets, T Bormann, A Rau, M Schwabenland, ... Brain 144 (4), 1263-1276, 2021 | 323 | 2021 |
| Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients G Blazhenets, N Schröter, T Bormann, J Thurow, D Wagner, L Frings, ... Journal of Nuclear Medicine 62 (7), 910-915, 2021 | 156 | 2021 |
| Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome A Dressing, T Bormann, G Blazhenets, N Schroeter, LI Walter, J Thurow, ... Journal of Nuclear Medicine 63 (7), 1058-1063, 2022 | 98 | 2022 |
| Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: a systematic review PT Meyer, S Hellwig, G Blazhenets, JA Hosp Journal of Nuclear Medicine 63 (7), 971-980, 2022 | 56 | 2022 |
| Principal components analysis of brain metabolism predicts development of Alzheimer dementia G Blazhenets, Y Ma, A Sörensen, G Rücker, F Schiller, D Eidelberg, ... Journal of Nuclear Medicine 60 (6), 837-843, 2019 | 55 | 2019 |
| Predictive value of 18F-florbetapir and 18F-FDG PET for conversion from mild cognitive impairment to Alzheimer dementia G Blazhenets, Y Ma, A Sörensen, F Schiller, G Rücker, D Eidelberg, ... Journal of Nuclear Medicine 61 (4), 597-603, 2020 | 45 | 2020 |
| Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms A Rau, N Schroeter, G Blazhenets, A Dressing, LI Walter, E Kellner, ... Brain 145 (9), 3203-3213, 2022 | 38 | 2022 |
| 18F-FDG PET imaging of the inferior colliculus in asymmetric hearing loss I Speck, S Arndt, J Thurow, G Blazhenets, A Aschendorff, PT Meyer, ... Journal of Nuclear Medicine 61 (3), 418-422, 2020 | 36 | 2020 |
| Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data A Sörensen, G Blazhenets, G Rücker, F Schiller, PT Meyer, L Frings, ... NeuroImage: Clinical 21, 101637, 2019 | 36 | 2019 |
| Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods A Sörensen, G Blazhenets, F Schiller, PT Meyer, L Frings, ... Alzheimer's Research & Therapy 12, 1-6, 2020 | 19 | 2020 |
| Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A: 11: C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study N Schröter, G Blazhenets, L Frings, C Barkhausen, WH Jost, C Weiller, ... Clinical nuclear medicine 45 (4), 283-287, 2020 | 19 | 2020 |
| Validation of the Alzheimer disease dementia conversion-related pattern as an ATN biomarker of neurodegeneration G Blazhenets, L Frings, Y Ma, A Sörensen, D Eidelberg, J Wiltfang, ... Neurology 96 (9), e1358-e1368, 2021 | 15 | 2021 |
| Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy J Brumberg, N Schröter, G Blazhenets, L Frings, J Volkmann, C Lapa, ... npj Parkinson's Disease 6 (1), 39, 2020 | 12 | 2020 |
| Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes N Schröter, G Blazhenets, L Frings, WH Jost, C Weiller, M Rijntjes, ... NPJ Parkinson's disease 8 (1), 123, 2022 | 9 | 2022 |
| Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes F D’Amore, F Grinberg, J Mauler, N Galldiks, G Blazhenets, E Farrher, ... Neuro-oncology advances 3 (1), vdab044, 2021 | 9 | 2021 |
| Brain activation patterns during visuomotor adaptation in motor experts and novices: An FDG PET study with unrestricted movements G Blazhenets, A Kurz, L Frings, C Leukel, PT Meyer Journal of Neuroscience Methods 350, 109061, 2021 | 8 | 2021 |
| Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators J Brumberg, G Blazhenets, N Schröter, L Frings, WH Jost, C Lapa, ... EJNMMI physics 6, 1-7, 2019 | 8 | 2019 |
| Principal-component analysis–based measures of PET data closely reflect neuropathologic staging schemes G Blazhenets, L Frings, A Sörensen, PT Meyer Journal of Nuclear Medicine 62 (6), 855-860, 2021 | 6 | 2021 |
| More extensive hypometabolism and higher mortality risk in patients with right-than left-predominant neurodegeneration of the anterior temporal lobe L Frings, G Blazhenets, R Binder, T Bormann, S Hellwig, PT Meyer Alzheimer's research & therapy 15 (1), 11, 2023 | 5 | 2023 |
| Cognitive Deficits in Parkinson's Disease Are Associated with Neuronal Dysfunction and Not White Matter Lesions N Schröter, T Bormann, M Rijntjes, G Blazhenets, R Berti, BEA Sajonz, ... Movement Disorders Clinical Practice 10 (7), 1066-1073, 2023 | 4 | 2023 |
Philipp T. MeyerProfessor, Nuclear Medicine, University of Freiburg, Germany在 uniklinik-freiburg.de 的电子邮件经过验证
